Alternatives to H1

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals. Here are the 52 closest alternatives, compared on pricing, features and what real users say.

H1 profile Open source alternatives (35)More Health alternatives

The 20 closest Health companies to H1

IQVIA
Not rated
Leveraging AI and advanced analytics to drive innovation in healthcare and life sciences.
Visit site
Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
Immunai
Not rated
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Visit site
Benchling
Not rated
R&D cloud platform for life sciences, enabling scientific innovation and productivity.
Visit site
Degron Therapeutics
Not rated
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Visit site
Enterome
Not rated
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Visit site
Adcendo
Not rated
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Visit site
Algorithmiq
Not rated
Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
Visit site
CellCentric
Not rated
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Visit site
Infinimmune
Not rated
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Visit site
Mironid
Not rated
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Visit site
Celerion
Not rated
A global leader in clinical pharmacology and bioanalytical sciences.
Visit site
Spark Therapeutics
Not rated
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Visit site
KaliVir Immunotherapeutics, Inc.
5.0 out of 5 (1)
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Visit site
QuantHealth
Not rated
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Visit site
Rocket Pharmaceuticals
Not rated
A biotechnology company developing genetic therapies for rare disorders.
Visit site
Janux Therapeutics
Not rated
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Visit site
Briya
3.0 out of 5 (1)
Platform for real-time retrieval and sharing of harmonized longitudinal clinical data.
Visit site
Lynx.MD
Not rated
Cloud platform for secure sharing and analysis of real-world health data for life sciences.
Visit site
Anagram Therapeutics
Not rated
Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Visit site

Company	Rating	Visit
IQVIALeveraging AI and advanced analytics to drive innovation in healthcare and life sciences.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.	Not rated	Visit site
BenchlingR&D cloud platform for life sciences, enabling scientific innovation and productivity.	Not rated	Visit site
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.	Not rated	Visit site
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.	Not rated	Visit site
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.	Not rated	Visit site
AlgorithmiqQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.	Not rated	Visit site
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.	Not rated	Visit site
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Not rated	Visit site
MironidBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).	Not rated	Visit site
CelerionA global leader in clinical pharmacology and bioanalytical sciences.	Not rated	Visit site
Spark TherapeuticsA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.	Not rated	Visit site
KaliVir Immunotherapeutics, Inc.Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.	5.0 out of 5 (1)	Visit site
QuantHealthAI-powered patient-centric drug simulations to accelerate and de-risk drug development.	Not rated	Visit site
Rocket PharmaceuticalsA biotechnology company developing genetic therapies for rare disorders.	Not rated	Visit site
Janux TherapeuticsA clinical-stage biopharmaceutical company developing novel immunotherapies.	Not rated	Visit site
BriyaPlatform for real-time retrieval and sharing of harmonized longitudinal clinical data.	3.0 out of 5 (1)	Visit site
Lynx.MDCloud platform for secure sharing and analysis of real-world health data for life sciences.	Not rated	Visit site
Anagram TherapeuticsClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the H1 profile.

Sponsored rows are paid and labelled. Advertise on this page